Cd28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major

Journal of Immunology

Volumn 168, Issue 3, 2002, Pages 1302-1308

  Compton, Helen L ^a   Farrell, Jay P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; IMMUNE RESPONSE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; T LYMPHOCYTE ACTIVATION; TH2 CELL;

EID: 0036467547     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.3.1302     Document Type: Article

References (62)

1. + lymphocytes in vivo during healing and progressive murine leishmaniasis
2. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis
3. IL-4 induces a Th2 response in Leishmania major-infected mice
4. + T cells which are NK 1:1
5. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis
6. T-cell subpopulations expression of interleukin-2 receptor, and production of interleukin-2 and γ interferon in human American cutaneous leishmaniasis
7. Leishmania aethiopica derived from diffuse leishmaniasis patients preferentially induce mRNA for interleukin-10 while those from localized leishmaniasis patients induce interferon-γ
8. Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-γ production
9. Interleukin 10 production correlates with pathology in human Leishmania donovani infections
10. Potential role for interleukin-10 in the immunosuppression associated with kala azar
11. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice
12. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: Evidence for a T cell-dependent, interferon γ-independent mechanism
13. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts
14. Transforming growth factor-β in leishmanial infection: A parasite escape mechanism
15. Recombinant interleukin 12 cures mice infected with Leishmania major
16. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type I immune response
17. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
18. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis
19. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice
20. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major
21. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge
22. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite
23. Leishmania major: Effect of infectious dose on T cell subset development in BALB/c mice
24. CD28/B7 system of T cell costimulation
25. Stat6 activation and Th2 cell proliferation driven by CD28 signals
26. Two distinct mechanisms of interleukin-2 gene expression in human T lymphocytes
27. L
28. L restores cell survival, but not proliferation or effector differentiation, in CD28-deficient T lymphocytes
29. The roles of CD28 and CD40 ligand in T cell activation and tolerance
30. Critical role of CD28 in protective immunity against Salmonella typhimurium
31. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: A comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade
32. + effector T cell responses
33. Duration of TCR stimulation determines costimulatory requirement of T cells
34. Differential T cell costimulatory requirements in CD28-deficient mice
35. + T cell effectors: Amplification of the lytic potential by B7
36. + T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile
37. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens
38. CD28 costimulation promotes the production of Th2 cytokines
39. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection
40. Blockade of CD28/B7 co-stimulation by mCTLA4-Hγ1 inhibits antigen-induced lung eosinophilia but not Th2 cell development or recruitment in the lung
41. CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen
42. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model
43. + T cells
44. + T cells
45. + T cell differentiation
46. Limited role of CD28-mediated signals in T helper subset differentiation
47. CTLA4 (CD152) modulates the Th subset response and alters the course of experimental Leishmania major infection
48. Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response
49. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes
50. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity
51. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis
52. Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response
53. + T cells in resistance to cutaneous leishmaniasis in immunized mice
54. + T cells
55. + T cells following secondary infection of mice immune to Leishmania major
56. + cytotoxic T cell responses
57. - T cells associated with cure of human cutaneous leishmaniasis
58. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection
59. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease
60. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites
61. Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: The effects of parasite dose, cyclophosphamide and sublethal irradiation
62. Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii